hep, Candy and his chubby girlfriend reporter from Oklahoma and Street Sweeper have a great track record for predictions on MDXG. They are batting .000
Medtronic is the odds on favorite......agree with Doc. Only given is that a buyout is a virtual certainty with the question being timing, 2015 or 2016.
Nope. Way too small for my radar. Projected revenue of $1 million in 2014 won't even cover their audit fee and D&O insurance. Keep in mind share count wiill go up as they raise cash because it appears they are years away from generating enough revenue to justify being a public company, ie the costs of being a public company.
Actually how_bout, reading your posts is the most effective sleep aid
rebecca, we all know you are that chubby "reporter" from Oklahoma who gets paid by Streetsweeper which has mob ties according to the United States Government. We all know your game. Good luck with your short, which isn't going very well for you. It's going to get worse for you. A lot worse.
@adamfeuerstein: $GALE CEO Mark Ahn has been fired by the company’s board of directors, a source close to the co. tells me. Public announcement tomorrow.
Osiris Flatline, Inc. because since 2007 the stock price has almost exactly flatlined. Been a great run for shareholders over the last 7 years. I see why so many of you are so ticked off.
will put link on SW forum but here is the section
TLSR: What are some of your favorite medical device companies?
WP: In the wound care space, my favorite company is MiMedx Group Inc. (MDXG:OTCBB), which is providing better, faster and cheaper technology compared to current therapies.
TLSR: Let's switch to wound healing. Tell me about MiMedx's amniotic membrane-based technology.
WP: Regarding advanced wound care, a patient will present with a diabetic foot ulcer or venous leg ulcer. These are different than standard wounds, with blood flow to the extremities being an issue. The continuum of care begins with a standard bandage. If that doesn't work, the next step is a more advanced bandage: silver coated or honey coated. If those don't work, more advanced technologies are required and can include negative pressure wound therapy, hyperbaric oxygen chambers, and advanced wound-covering technologies. MiMedx is focused on advanced wound-covering/regeneration technologies in the skin substitute market.
MiMedx uses amniotic tissue derived from live birth placenta. Published clinical data demonstrated a 92% wound-healing rate in diabetic foot ulcers. Patients typically require two or three grafts, with a total cost per patient of $2-3K.
Since commercializing its products over the last several years, MiMedx has grown significantly and has taken a significant portion of market share. The products work well, reimbursement is in place and distribution continues to ramp to properly address the U.S. market.
market, I believe MDXG has 5 analysts covering the company. How many does OSIR have?
1/4 inch? What is that you wee wee size? You obviously know nothing about EpiFix to make that statement. MDXG like every other public company in the space that has an advisory board,compensates members with options. Much more prudent method than using precious cash. You talk like the company is giving stock to the doctors and hospitals who are BUYING Epifix. Nonsense. Have "some business"? You mean volume that dwarfs Grafix? As for Petit not answering any more questions, you mean from that smelly dimwitted analyst who wanted to know confidential information as far as what MDXG's compensation is? Maybe he should also tell Streetsweeper's analyst partner what the sales people et in terms of healthcare coverage, vacation days and lunch breaks too?
Give it up Ozark. Thousands upon thousands of uses of EpiFIx with stellar results, including government hospitals and doctors, who not only continue ordering EpiFix because of its success rate but continue to order it in bigger quantity because it works so well and it is cost effective. You can babble all you want about the studies, it's all a bunch of hot air. The best study possible is the real world where way more docs and hospitals are using EpiFix than Grafix and for good reason. You really think they are using it and continue to use if if it doesn't work and doesn't work at the success level level that MDXG's studies have shown" If docs ate told a product reduces DFY by x% in x days and they buy it and the product doesn't work as represented, do you think they will continue to use it? You are clueless how docs and hospitals work. I could care less who was on the panel. The only thing that matters is that EpiFix results are stellar and that is PROVEN bu the exploding sales.
The Art and Science of High Definition Ultrasound in Joint and Soft Tissue Rejuvenation
Posted on August 17, 2014 by admin
By Suzi Harkola
The pain of arthritis or injury in joints and soft tissues can be debilitating and excruciating. For years, the only option was highly invasive surgery, with extended periods of rehabilitation and limited mobility. Patients undergoing this type of treatment often feel depressed, isolated, compromised and – all too often – still in pain.
Alternatives to surgery are coming into their own. While not for every situation, non-surgical techniques can often rejuvenate bone and repair soft tissue damage.
A Sarasota medical facility, Gecko Joint & Spine, is one of the leading providers of rejuvenation therapy, and has been for well over a decade. Using injections of Prolozone, stem cells and platelet rich plasma, Gecko’s medical team has perfected the art and science of joint repair without surgery. The clinic has become a mecca for people from around the world to experience pain relief through injection therapy.
One key to Gecko’s success, according to John Lieurance, D.C., is the use of high definition ultrasound (US) to pinpoint, literally, the exact site for the injections. “We specialize in preparation for the injections,” he explained, “and the high def US shows us exactly what’s wrong so we can isolate the injection location. Ultrasound is actually better than an MRI or X-ray to identify damage to tendons, ligaments and soft tissue, and to visualize abnormal fluid. It’s immediate, and gives us a hands-on analysis of the musculoskeletal system. Most importantly, it ensures accurate, efficient and often less painful procedures because of the accuracy it provides for the injection.”